Thermo Fisher Scientific Inc. (TMO) capitalization

Current snapshot

Market Cap
$178.33B
378.0M shares × $480.05
Net Worth
$53.41B
Stockholders' equity · 2025-12-31
Enterprise Value
$209.08B
Market cap + debt − cash
Net Debt
$30.75B
Debt $40.85B − Cash $10.11B

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $219.03B
FY'24 2024-12-31 $199.25B
FY'23 2023-12-31 $205.95B
FY'22 2022-12-31 $216.97B
FY'21 2021-12-31 $264.89B
FY'20 2020-12-31 $185.85B
FY'19 2019-12-31 $130.92B
FY'18 2018-12-31 $90.86B
FY'17 2017-12-31 $75.57B
FY'16 2016-12-31 $56.02B
FY'15 2015-12-31 $57.02B
FY'14 2014-12-31 $50.40B
FY'13 2013-12-31 $40.73B
FY'12 2012-12-31 $23.38B
FY'11 2011-12-31 $17.30B
FY'10 2010-12-31 $22.66B
FY'09 2009-12-31 $20.16B

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q4'25 2025-12-31 $219.03B
Q3'25 2025-09-27 $175.48B
Q2'25 2025-06-28 $154.33B
Q1'25 2025-03-29 $189.56B
Q4'24 2024-12-31 $199.25B
Q3'24 2024-09-28 $235.94B
Q2'24 2024-06-29 $211.80B
Q1'24 2024-03-30 $223.18B
Q4'23 2023-12-31 $205.95B
Q3'23 2023-09-30 $196.39B
Q2'23 2023-07-01 $202.44B
Q1'23 2023-04-01 $223.63B
Q4'22 2022-12-31 $216.97B
Q3'22 2022-10-01 $200.34B
Q2'22 2022-07-02 $216.02B
Q1'22 2022-04-02 $233.97B
Q4'21 2021-12-31 $264.89B
Q3'21 2021-10-02 $227.37B
Q2'21 2021-07-03 $203.27B
Q1'21 2021-04-03 $181.15B
Q4'20 2020-12-31 $185.85B
Q3'20 2020-09-26 $168.49B
Q2'20 2020-06-27 $139.68B
Q1'20 2020-03-28 $109.74B
Q4'19 2019-12-31 $130.92B
Q3'19 2019-09-28 $116.11B
Q2'19 2019-06-29 $118.35B
Q1'19 2019-03-30 $110.31B
Q4'18 2018-12-31 $90.86B
Q3'18 2018-09-29 $99.10B
Q2'18 2018-06-30 $84.10B
Q1'18 2018-03-31 $83.82B
Q1'18 2018-01-01
Q4'17 2017-12-31 $75.57B
Q3'17 2017-09-30 $75.68B
Q2'17 2017-07-01 $68.57B
Q1'17 2017-04-01 $60.52B
Q4'16 2016-12-31 $56.02B
Q3'16 2016-10-01 $63.21B
Q2'16 2016-07-02 $59.20B
Q1'16 2016-04-02 $56.88B
Q4'15 2015-12-31 $57.02B
Q3'15 2015-09-26 $49.31B
Q2'15 2015-06-27 $53.08B
Q1'15 2015-03-28 $53.66B
Q4'14 2014-12-31 $50.40B
Q3'14 2014-09-27 $48.99B
Q2'14 2014-06-28 $47.69B
Q1'14 2014-03-29 $47.21B
Q4'13 2013-12-31 $40.73B
Q3'13 2013-09-28 $34.16B
Q2'13 2013-06-29 $30.76B
Q1'13 2013-03-30 $27.67B
Q4'12 2012-12-31 $23.38B
Q3'12 2012-09-29 $21.50B
Q2'12 2012-06-30 $19.17B
Q1'12 2012-03-31 $20.87B
Q4'11 2011-12-31 $17.30B
Q3'11 2011-10-01 $19.38B
Q2'11 2011-07-02 $25.09B
Q1'11 2011-04-02 $22.09B
Q4'10 2010-12-31 $22.66B
Q3'10 2010-10-02 $19.34B
Q2'10 2010-07-03 $19.79B
Q1'10 2010-04-03 $21.65B
Q4'09 2009-12-31 $20.16B
Q3'09 2009-09-26 $18.49B
Q2'09 2009-06-27 $17.76B
Q1'10 2009-03-28 $15.57B
Q2'09 2008-12-31 $14.81B
Q3'09 2008-09-27 $24.82B
Q2'09 2008-06-28 $24.18B
Q2'09 2007-12-31 $25.59B

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (TMO CIK 0000097745), tagged with the us-gaap and dei taxonomies. The only exception is the live market cap tile, which uses the current share price × shares outstanding from a market quote. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.